These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29765222)

  • 21. Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.
    Beslon V; Moreau P; Maruani A; Maisonneuve H; Giraudeau B; Fournier JP
    J Gen Intern Med; 2018 Mar; 33(3):358-366. PubMed ID: 29204974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of the Morisky Medication Adherence Scale in gout: a prospective study.
    Tan C; Teng GG; Chong KJ; Cheung PP; Lim A; Wee HL; Santosa A
    Patient Prefer Adherence; 2016; 10():2449-2457. PubMed ID: 27980395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review.
    Gill I; Dalbeth N; 'Ofanoa M; Goodyear-Smith F
    BJGP Open; 2020 Aug; 4(3):. PubMed ID: 32636201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist-managed titration of urate-lowering therapy to streamline gout management.
    Huang IJ; Liew JW; Morcos MB; Zuo S; Crawford C; Bays AM
    Rheumatol Int; 2019 Sep; 39(9):1637-1641. PubMed ID: 31147732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient and provider barriers to effective management of gout in general practice: a qualitative study.
    Spencer K; Carr A; Doherty M
    Ann Rheum Dis; 2012 Sep; 71(9):1490-5. PubMed ID: 22440822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO
    BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring quality of gout management in residential aged care facilities.
    Nguyen AD; Lind KE; Day RO; Ross D; Raban MZ; Georgiou A; Westbrook JI
    Rheumatol Adv Pract; 2022; 6(3):rkac091. PubMed ID: 36465481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
    Doherty M; Jenkins W; Richardson H; Sarmanova A; Abhishek A; Ashton D; Barclay C; Doherty S; Duley L; Hatton R; Rees F; Stevenson M; Zhang W
    Lancet; 2018 Oct; 392(10156):1403-1412. PubMed ID: 30343856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health literacy in patients dealing with gout: a qualitative study.
    van Onna M; Hinsenveld E; de Vries H; Boonen A
    Clin Rheumatol; 2015 Sep; 34(9):1599-603. PubMed ID: 25501463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
    Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
    Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Education and non-pharmacological approaches for gout.
    Abhishek A; Doherty M
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i51-i58. PubMed ID: 29272507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?
    Latif Z; Abhishek A
    Curr Rheumatol Rep; 2018 Mar; 20(3):14. PubMed ID: 29516289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis.
    Zhang T; Pope JE
    Rheumatology (Oxford); 2017 Jul; 56(7):1144-1153. PubMed ID: 28379501
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.